_id
6917207c3c536f8df231689a
Ticker
TOMDF
Name
Todos Medical Ltd
Exchange
PINK
Address
121 Derech Menachem Begin, Tel Aviv-Yafo, Israel, 6701203
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://todosmedical.com
Description
Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv-Yafo, Israel.
Last Close
-
Volume
-
Current Price
0
Change
0
Last Updated
2026-01-07T13:20:33.238Z
Image
https://logo.clearbit.com/todosmedical.com
Ipo Date
-
Market Cap
21304
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-09-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
2130423853
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
-39586
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
-
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
45
Deep Value Investing Score
0
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
1
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
1.5
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
0
Quarters > 0 > quarter
2023-09-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
1425643006
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-39586
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
-
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
45
Quarters > 1 > quarter
2023-06-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
1425643006
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
-
Quarters > 1 > balance Sheet > property Plant Equipment
-
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
-
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-
Quarters > 1 > cash Flow > depreciation
122085
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
-
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2023-03-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
1425643006
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-
Quarters > 2 > cash Flow > depreciation
41584
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
1403000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
1403000
Quarters > 3 > income Statement > operating Expenses
3285313
Quarters > 3 > income Statement > operating Income
-2048000
Quarters > 3 > income Statement > interest Expense
3115000
Quarters > 3 > income Statement > pretax Income
-4920000
Quarters > 3 > income Statement > net Income
-4993000
Quarters > 3 > income Statement > eps
-0.0035022793076431645
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
1425643006
Quarters > 3 > income Statement > income Tax Expense
73003
Quarters > 3 > income Statement > EBITDA
-1882313
Quarters > 3 > income Statement > operating Margin
-145.9729151817534
Quarters > 3 > income Statement > total Other Income Expense Net
-2872000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
34000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1048000
Quarters > 3 > balance Sheet > inventories
1021000
Quarters > 3 > balance Sheet > total Current Assets
3372000
Quarters > 3 > balance Sheet > property Plant Equipment
1437000
Quarters > 3 > balance Sheet > total Assets
15267000
Quarters > 3 > balance Sheet > payables
6603000
Quarters > 3 > balance Sheet > short Term Debt
5301000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
50157000
Quarters > 3 > balance Sheet > equity
-35512000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-4993000
Quarters > 3 > cash Flow > depreciation
165687
Quarters > 3 > cash Flow > change In Working Capital
1268878
Quarters > 3 > cash Flow > cash From Operations
-796961
Quarters > 3 > cash Flow > capital Expenditures
1680859
Quarters > 3 > cash Flow > cash From Investing
12315
Quarters > 3 > cash Flow > cash From Financing
763400
Quarters > 3 > cash Flow > net Change In Cash
-23000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-0.0035022793076431645
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
14.060036044154089
Quarters > 3 > ratios > ROA
-32.704526102050174
Quarters > 3 > ratios > FCF
-2477820
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-1.7660869565217392
Quarters > 3 > health Score
30
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
7695000
Annuals > 0 > income Statement > cost Of Revenue
3385000
Annuals > 0 > income Statement > gross Profit
4310000
Annuals > 0 > income Statement > operating Expenses
14058000
Annuals > 0 > income Statement > operating Income
-9748000
Annuals > 0 > income Statement > interest Expense
14850000
Annuals > 0 > income Statement > pretax Income
-24981000
Annuals > 0 > income Statement > net Income
-24994000
Annuals > 0 > income Statement > eps
-0.01753173823657786
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
1425643006
Annuals > 0 > income Statement > income Tax Expense
13000
Annuals > 0 > income Statement > EBITDA
-9394000
Annuals > 0 > income Statement > operating Margin
-126.6796621182586
Annuals > 0 > income Statement > total Other Income Expense Net
-15233000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
34000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
1048000
Annuals > 0 > balance Sheet > inventories
1021000
Annuals > 0 > balance Sheet > total Current Assets
3372000
Annuals > 0 > balance Sheet > property Plant Equipment
1437000
Annuals > 0 > balance Sheet > total Assets
15267000
Annuals > 0 > balance Sheet > payables
6603000
Annuals > 0 > balance Sheet > short Term Debt
5301000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
50157000
Annuals > 0 > balance Sheet > equity
-35512000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-24994000
Annuals > 0 > cash Flow > depreciation
750000
Annuals > 0 > cash Flow > change In Working Capital
4747000
Annuals > 0 > cash Flow > cash From Operations
-2713000
Annuals > 0 > cash Flow > capital Expenditures
74000
Annuals > 0 > cash Flow > cash From Investing
-1807000
Annuals > 0 > cash Flow > cash From Financing
4365000
Annuals > 0 > cash Flow > net Change In Cash
-155000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.01753173823657786
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
70.38184275737778
Annuals > 0 > ratios > ROA
-163.71258269470098
Annuals > 0 > ratios > FCF
-2787000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.3621832358674464
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
12230000
Annuals > 1 > income Statement > cost Of Revenue
7847000
Annuals > 1 > income Statement > gross Profit
4383000
Annuals > 1 > income Statement > operating Expenses
13669000
Annuals > 1 > income Statement > operating Income
-9286000
Annuals > 1 > income Statement > interest Expense
31178000
Annuals > 1 > income Statement > pretax Income
-43314000
Annuals > 1 > income Statement > net Income
-43314000
Annuals > 1 > income Statement > eps
-0.06373693977659398
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
679574516
Annuals > 1 > income Statement > income Tax Expense
31607000
Annuals > 1 > income Statement > EBITDA
-9715000
Annuals > 1 > income Statement > operating Margin
-75.92804578904334
Annuals > 1 > income Statement > total Other Income Expense Net
-34028000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
189000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
2520000
Annuals > 1 > balance Sheet > inventories
1603000
Annuals > 1 > balance Sheet > total Current Assets
4716000
Annuals > 1 > balance Sheet > property Plant Equipment
2188000
Annuals > 1 > balance Sheet > total Assets
15115000
Annuals > 1 > balance Sheet > payables
2276000
Annuals > 1 > balance Sheet > short Term Debt
2023000
Annuals > 1 > balance Sheet > long Term Debt
29588000
Annuals > 1 > balance Sheet > total Liabilities
39327000
Annuals > 1 > balance Sheet > equity
-24212000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-43314000
Annuals > 1 > cash Flow > depreciation
763000
Annuals > 1 > cash Flow > change In Working Capital
-1211000
Annuals > 1 > cash Flow > cash From Operations
-11224000
Annuals > 1 > cash Flow > capital Expenditures
1097000
Annuals > 1 > cash Flow > cash From Investing
-4706000
Annuals > 1 > cash Flow > cash From Financing
15184000
Annuals > 1 > cash Flow > net Change In Cash
-746000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.06373693977659398
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
178.89476292747398
Annuals > 1 > ratios > ROA
-286.56301687065826
Annuals > 1 > ratios > FCF
-12321000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.0074407195421096
Annuals > 1 > health Score
34
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
5207000
Annuals > 2 > income Statement > cost Of Revenue
3818000
Annuals > 2 > income Statement > gross Profit
1389000
Annuals > 2 > income Statement > operating Expenses
15650000
Annuals > 2 > income Statement > operating Income
-14261000
Annuals > 2 > income Statement > interest Expense
3495000
Annuals > 2 > income Statement > pretax Income
-29773000
Annuals > 2 > income Statement > net Income
-29773000
Annuals > 2 > income Statement > eps
-0.11487536597689217
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
259176541
Annuals > 2 > income Statement > income Tax Expense
2631000
Annuals > 2 > income Statement > EBITDA
-24982000
Annuals > 2 > income Statement > operating Margin
-273.8813136162858
Annuals > 2 > income Statement > total Other Income Expense Net
-15512000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
935000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
378000
Annuals > 2 > balance Sheet > inventories
536000
Annuals > 2 > balance Sheet > total Current Assets
2450000
Annuals > 2 > balance Sheet > property Plant Equipment
1999000
Annuals > 2 > balance Sheet > total Assets
6009000
Annuals > 2 > balance Sheet > payables
1640000
Annuals > 2 > balance Sheet > short Term Debt
2978000
Annuals > 2 > balance Sheet > long Term Debt
8465000
Annuals > 2 > balance Sheet > total Liabilities
17020000
Annuals > 2 > balance Sheet > equity
-11011000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-29773000
Annuals > 2 > cash Flow > depreciation
96000
Annuals > 2 > cash Flow > change In Working Capital
1727000
Annuals > 2 > cash Flow > cash From Operations
-2558000
Annuals > 2 > cash Flow > capital Expenditures
2480000
Annuals > 2 > cash Flow > cash From Investing
-3616000
Annuals > 2 > cash Flow > cash From Financing
7092000
Annuals > 2 > cash Flow > net Change In Cash
918000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.11487536597689217
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
270.3932431205159
Annuals > 2 > ratios > ROA
-495.47345648194374
Annuals > 2 > ratios > FCF
-5038000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-0.9675436911849433
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
29643
Annuals > 3 > income Statement > gross Profit
-29643
Annuals > 3 > income Statement > operating Expenses
3515216
Annuals > 3 > income Statement > operating Income
-3515216
Annuals > 3 > income Statement > interest Expense
958741
Annuals > 3 > income Statement > pretax Income
-11814515
Annuals > 3 > income Statement > net Income
-9807455
Annuals > 3 > income Statement > eps
-0.10657475184676446
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
92024188
Annuals > 3 > income Statement > income Tax Expense
-2007060
Annuals > 3 > income Statement > EBITDA
-7780807
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-8299299
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
12155
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
0
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
26229
Annuals > 3 > balance Sheet > property Plant Equipment
64672
Annuals > 3 > balance Sheet > total Assets
90901
Annuals > 3 > balance Sheet > payables
414460
Annuals > 3 > balance Sheet > short Term Debt
112635
Annuals > 3 > balance Sheet > long Term Debt
3737684
Annuals > 3 > balance Sheet > total Liabilities
6339713
Annuals > 3 > balance Sheet > equity
-6248812
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-11814515
Annuals > 3 > cash Flow > depreciation
29643
Annuals > 3 > cash Flow > change In Working Capital
975850
Annuals > 3 > cash Flow > cash From Operations
-1276239
Annuals > 3 > cash Flow > capital Expenditures
1073
Annuals > 3 > cash Flow > cash From Investing
-448694
Annuals > 3 > cash Flow > cash From Financing
1669470
Annuals > 3 > cash Flow > net Change In Cash
-55463
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.10657475184676446
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
156.94911288737762
Annuals > 3 > ratios > ROA
-10789.160735305442
Annuals > 3 > ratios > FCF
-1277312
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
28
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
27
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
20
Updated At
2026-01-20T22:42:44.754Z
Earnings History > 0 > period
2022-12-31
Earnings History > 0 > report Date
2022-12-31
Earnings History > 0 > date
2022-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0035
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2022-09-30
Earnings History > 1 > report Date
2022-11-14
Earnings History > 1 > date
2022-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0044
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-06-30
Earnings History > 2 > report Date
2022-08-22
Earnings History > 2 > date
2022-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.01
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-03-31
Earnings History > 3 > report Date
2022-05-16
Earnings History > 3 > date
2022-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.01
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-12-31
Earnings History > 4 > report Date
2022-03-31
Earnings History > 4 > date
2021-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.02
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-09-30
Earnings History > 5 > report Date
2021-11-15
Earnings History > 5 > date
2021-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.01
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-09-24
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0.01
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-06-22
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.04
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-12-31
Earnings History > 8 > report Date
2021-03-31
Earnings History > 8 > date
2020-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.04
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.04
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-06-30
Earnings History > 9 > report Date
2020-09-30
Earnings History > 9 > date
2020-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.0701
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0701
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2020-03-31
Earnings History > 10 > report Date
2020-06-30
Earnings History > 10 > date
2020-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.0136
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0136
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-12-31
Earnings History > 11 > report Date
2020-03-31
Earnings History > 11 > date
2019-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.0333
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.0333
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2015-09-30
Earnings History > 12 > report Date
2015-12-31
Earnings History > 12 > date
2015-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.0027
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.0027
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2015-06-30
Earnings History > 13 > report Date
2015-09-30
Earnings History > 13 > date
2015-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.0027
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.0027
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2015-03-31
Earnings History > 14 > report Date
2015-06-30
Earnings History > 14 > date
2015-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.0059
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0059
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2014-12-31
Earnings History > 15 > report Date
2015-03-31
Earnings History > 15 > date
2014-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.0059
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0059
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2014-09-30
Earnings History > 16 > report Date
2014-12-31
Earnings History > 16 > date
2014-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.0018
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.0018
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2014-06-30
Earnings History > 17 > report Date
2014-09-30
Earnings History > 17 > date
2014-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.0018
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0018
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2014-03-31
Earnings History > 18 > report Date
2014-06-30
Earnings History > 18 > date
2014-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.0034
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0034
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2013-12-31
Earnings History > 19 > report Date
2014-03-31
Earnings History > 19 > date
2013-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.0034
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0034
Earnings History > 19 > surprise Percent
-
Todos Medical Ltd., a vitro diagnostics company, develops and commercializes blood tests for the detection of cancer and Alzheimer disease in the United States. The company develops Total Biochemical Infrared Analysis, a proprietary cancer-screening technology using peripheral blood spectroscopy analysis for examination into cancer's influence on the immune system; Lymphocyte Proliferation Test, a diagnostic blood test that determines the ability of peripheral blood lymphocytes and monocytes to withstand an exogenous mitogenic stimulation that induces them to enter the cell cycle; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis products include TM-B1 and TM-B2 for breast cancer tests; and TMC blood test for the screening and diagnosis of colon cancer. The company also offers Tollovid, a 3CL protease inhibitor dietary supplement to support healthy immune function against circulating coronaviruses; and Tollovir, an antiviral treatment for Covid-19 that is in Phase 2 clinical trial. Todos Medical Ltd. has a collaboration agreement with Integrated Health LLC, as well as has agreements with various companies to develop screening tests for SARS-nCoV-2; and to distribute certain COVID-19 test kits. Todos Medical Ltd. was incorporated in 2010 and is headquartered in Tel Aviv-Yafo, Israel.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-09-30)
Health Score
* Institutions hold a combined 0.00% of the total shares of Todos Medical Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2022-12-31
EPS Actual
-0.0035
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2023-09-30)
(Last Updated 2023-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.